FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns a pharmaceutical composition in the form of a film-coated tablet. As an active substance, the composition contains moxifloxacin hydrochloride in a therapeutically effective amount, and auxiliary ingredients, i.e. silicon dioxide, sodium croscarmellose, an excipient and a lubricant, but it is free from lactose. The excipient represents microcrystalline cellulose or its combination with magnesium carbonate basic. A method for producing the composition involves mixing powders of moxifloxacin hydrochloride, excipient, silicon dioxide, moisturising, granulating, drying, lubricating, tabletting and coating.
EFFECT: preparation is applicable to control bacterial infections and possesses stability, adequate strength, good appearance and high release rate.
7 cl, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN AND METHOD FOR PRODUCING IT | 2014 |
|
RU2558932C1 |
| STABLE FORMULATIONS OF IMANITIB | 2008 |
|
RU2470641C2 |
| 1-CYCLOPROPYL-7-([S,S]-2,8-DIAZABICYCLO[4,3,0]NONE-8-YL)-6- -FLUORO-1,4-DIHYDRO-8-METHOXY-4-OXO-3-QUINOLINE CARBOXYLIC ACID HYDROCHLORIDE MONOHYDRATE AND PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 1996 |
|
RU2162468C2 |
| CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)BENZOXAZOLE | 2015 |
|
RU2692252C2 |
| PHARMACEUTICAL COMPOSITION OF CYCLOBENZAPRINE AND ITS USE | 2022 |
|
RU2794957C1 |
| NORADRENERGIC AND SPECIFICALLY SEROTONERGIC ANXIOLYTIC AND ANTIDEPRESSANT, ITS PRODUCTION AND APPLICATION METHOD | 2020 |
|
RU2775772C2 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION CONTAINING GLUCOKINASE ACTIVATOR AND BIGUANIDE HYPOGLYCEMIC DRUG, AS WELL AS THEIR PREPARATION METHOD, AND THEIR USE | 2019 |
|
RU2780377C2 |
| SOLID PREPARATIONS CONTAINING TOFOGLIFLOZIN, AND METHOD FOR PRODUCTION THEREOF | 2014 |
|
RU2700164C2 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION OF PROLONGED ACTION | 2011 |
|
RU2465896C2 |
